{"schema_version":"alpha-profile-public-v1","slug":"charles-baum-m-d-ph-d","canonical_url":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d","as_of":"2026-09-22T00:15:25.331037+00:00","published_at":"2026-09-02T02:37:24.554434+00:00","last_reviewed_at":"2026-05-15T21:42:20.392+00:00","identity":{"display_name":"Charles Baum, M.D., Ph.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Acrivon Therapeutics, Inc.","company_slug":"acrivon-therapeutics-inc","exchange":"NASDAQ","ticker":"ACRV","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-24T20:10:02.508+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=charles-baum-m-d-ph-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=charles-baum-m-d-ph-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Baum has served as CEO of Terremoto Biosciences since July 2024. He was Founder, President and CEO of Mirati Therapeutics from 2012 to 2021 and again from August 2023 until its acquisition by Bristol Myers Squibb in January 2024. He has extensive experience in oncology research and development and serves on multiple biotechnology company boards."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Acrivon Therapeutics, Inc.","organizationId":"acrivon-therapeutics-inc","title":"Director","period":"2023-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Acrivon Therapeutics, Inc.","company_slug":"acrivon-therapeutics-inc","exchange":"NASDAQ","ticker":"ACRV","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","effective_date":"2025-04-25","last_checked_at":"2026-04-24T20:10:02.508+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Charles Baum, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:20.57215+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:20.471448+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Charles Baum, M.D., Ph.D. currently serves as Director at Acrivon Therapeutics, Inc..","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:20.53673+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:20.471448+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation","Nominating/Governance"],"claim_text":"Charles Baum, M.D., Ph.D. serves on Compensation, Nominating/Governance.","claim_state":"verified","valid_from":"2025-04-25","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:20.554996+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:20.471448+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Terremoto Biosciences","claim_text":"Charles Baum, M.D., Ph.D. is linked to Terremoto Biosciences as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:20.672199+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:20.471448+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer","claim_text":"Charles Baum, M.D., Ph.D. is also listed as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:20.65443+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:20.471448+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Charles Baum, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:20.604651+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:20.471448+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Charles Baum, M.D., Ph.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:42:20.587922+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ACRV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","published_at":"2025-04-25T00:00:00+00:00","last_checked_at":"2026-05-15T21:42:20.471448+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:charles-baum-m-d-ph-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2023-01-01 · current","organization":"Acrivon Therapeutics, Inc.","organization_id":"acrivon-therapeutics-inc"},"claim_text":"Director at Acrivon Therapeutics, Inc. (2023-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d#profile","url":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d","dateModified":"2026-05-15T21:42:20.392+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d#person","name":"Charles Baum, M.D., Ph.D.","url":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Acrivon Therapeutics, Inc.","tickerSymbol":"NASDAQ: ACRV"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","memberOf":{"@type":"Organization","name":"Acrivon Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/acrivon-therapeutics-inc","tickerSymbol":"NASDAQ: ACRV"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1781174/000095017025058352/acrv-20250424.htm","name":"ACRV DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-15T21:42:20.392+00:00","observed_at":"2026-09-22T00:15:25.331037+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"charles-baum-m-d-ph-d","canonical_url":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d"},"publication":{"published_at":"2026-09-02T02:37:24.554434+00:00","last_reviewed_at":"2026-05-15T21:42:20.392+00:00","as_of":"2026-09-22T00:15:25.331037+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/charles-baum-m-d-ph-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/charles-baum-m-d-ph-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}